Literature DB >> 25268763

Dipeptidyl peptidase-4 (DPP-4): Localization and activity in human and rodent islets.

Liehua Liu1, Bilal Omar2, Piero Marchetti3, Bo Ahrén4.   

Abstract

Dipeptidyl peptidase 4 (DPP-4) was recently found to be expressed in human and mouse islets with different expression patterns. However, whether species-dependent expression pattern is a generalized phenomenon and whether islet DPP-4 activity is regulated are not known. This study was conducted to investigate DPP-4 localization in several different species, and to examine the impact of glucose, incretin hormones, and insulin on islet DPP-4 activity. It was shown by immuofluorescent staining that there were two distinct species-specific expression patterns of islet DPP-4. The enzyme was expressed exclusively in α-cells in human and pig islets, but primarily in β-cells in mouse and rat islets. INS-1 832/13 cells also expressed DPP-4, and inhibition of DPP-4 enhanced insulin secretion in the presence of glucagon-like peptide-1 (GLP-1) in the cells. DPP-4 activity was remarkably robust when cultured with high glucose, incretin hormones, and insulin in mouse and human islets as well as INS-1 832/13 cells and islet DPP-4 activity and expression pattern was not altered in double incretin receptor knockout mice, compared to wild type mice. We conclude that islet DPP-4 is species-specifically expressed in α-cell and β-cell dominant patterns in several species and both patterns remained robust in enzyme activity during short-term metabolic challenge.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dipeptidyl peptidase 4; Incretin; Islet of Langerhans; Type 2 diabetes

Mesh:

Substances:

Year:  2014        PMID: 25268763     DOI: 10.1016/j.bbrc.2014.09.096

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism.

Authors:  Bo Ahrén; James E Foley
Journal:  Diabetologia       Date:  2016-02-19       Impact factor: 10.122

2.  Dipeptidyl peptidase-4 expression in pancreatic tissue from patients with congenital hyperinsulinism.

Authors:  Sofia A Rahman; Senthil Senniappan; Maha Sherif; Sophia Tahir; Khalid Hussain
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

3.  Saxagliptin Induces β-Cell Proliferation through Increasing Stromal Cell-Derived Factor-1α In Vivo and In Vitro.

Authors:  Chun-Jun Li; Bei Sun; Qian-Hua Fang; Min Ding; Yun-Zhi Xing; Li-Ming Chen; De-Min Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-27       Impact factor: 5.555

Review 4.  Evidence for the existence and potential roles of intra-islet glucagon-like peptide-1.

Authors:  Scott A Campbell; Janyne Johnson; Peter E Light
Journal:  Islets       Date:  2021-03-16       Impact factor: 2.694

Review 5.  Mechanisms of Beta-Cell Apoptosis in Type 2 Diabetes-Prone Situations and Potential Protection by GLP-1-Based Therapies.

Authors:  Safia Costes; Gyslaine Bertrand; Magalie A Ravier
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

Review 6.  DPP4 in Diabetes.

Authors:  Diana Röhrborn; Nina Wronkowitz; Juergen Eckel
Journal:  Front Immunol       Date:  2015-07-27       Impact factor: 7.561

7.  Sitagliptin and Roux-en-Y gastric bypass modulate insulin secretion via regulation of intra-islet PYY.

Authors:  Claudia Guida; Laura J McCulloch; Mahdieh Godazgar; Sam D Stephen; Charlotte Baker; Davide Basco; Jiawen Dong; Duan Chen; Anne Clark; Reshma D Ramracheya
Journal:  Diabetes Obes Metab       Date:  2017-10-10       Impact factor: 6.577

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.